Baseline characteristics for 1000 patients by treatment status
| Corticosteroid n (%) | Placebo n (%) | Total | |
|---|---|---|---|
| Age at randomisation (y) | |||
| 16–24 | 133 (27) | 126 (25) | 259 |
| 25–34 | 113 (23) | 114 (23) | 227 |
| 35–54 | 141 (28) | 152 (30) | 293 |
| 55+ | 109 (22) | 112 (22) | 221 |
| Sex | |||
| Male | 393 (79) | 388 (77) | 781 |
| Female | 103 (21) | 116 (23) | 219 |
| Glasgow Coma Scale | |||
| Severe (GCS 3-8) | 196 (40) | 185 (37) | 381 |
| Moderate (GCS 9-12) | 146 (29) | 143 (28) | 289 |
| Mild (GCS 13-14) | 154 (31) | 176 (35) | 330 |
| Time since injury | |||
| Less than or equal to 1h | 211 (42) | 193 (38) | 404 |
| Over 1 h, less than or equal to 3 h | 143 (29) | 162 (32) | 305 |
| Over 3 h, less than 8 h | 142 (29) | 149 (30) | 291 |
| Localising signs | 69 (14) | 87 (17) | 156 |
| No localising signs | 427 (86) | 417 (83) | 844 |
| All patients | 496 | 504 | 1000 |